BactiQuant Statistics

Total Valuation

BactiQuant has a market cap or net worth of DKK 105.44 million. The enterprise value is 105.74 million.

Market Cap	105.44M
Enterprise Value	105.74M

Important Dates

The last earnings date was Thursday, December 4, 2025.

Earnings Date	Dec 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BactiQuant has 29.37 million shares outstanding. The number of shares has increased by 17.17% in one year.

Current Share Class	29.37M
Shares Outstanding	29.37M
Shares Change (YoY)	+17.17%
Shares Change (QoQ)	+25.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.76
PB Ratio	13.18
P/TBV Ratio	27.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.08
EV / Sales	12.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.18

Financial Position

The company has a current ratio of 4.66, with a Debt / Equity ratio of 1.02.

Current Ratio	4.66
Quick Ratio	3.26
Debt / Equity	1.02
Debt / EBITDA	n/a
Debt / FCF	-0.78
Interest Coverage	-8.17

Financial Efficiency

Return on equity (ROE) is -176.46% and return on invested capital (ROIC) is -64.53%.

Return on Equity (ROE)	-176.46%
Return on Assets (ROA)	-41.75%
Return on Invested Capital (ROIC)	-64.53%
Return on Capital Employed (ROCE)	-74.71%
Revenue Per Employee	750,982
Profits Per Employee	-1.19M
Employee Count	11
Asset Turnover	0.47
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.70% in the last 52 weeks. The beta is 0.60, so BactiQuant's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-10.70%
50-Day Moving Average	2.60
200-Day Moving Average	2.82
Relative Strength Index (RSI)	66.38
Average Volume (20 Days)	107,840

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BactiQuant had revenue of DKK 8.26 million and -13.08 million in losses. Loss per share was -0.49.

Revenue	8.26M
Gross Profit	-2.63M
Operating Income	-11.85M
Pretax Income	-13.08M
Net Income	-13.08M
EBITDA	-11.27M
EBIT	-11.85M
Loss Per Share	-0.49

Full Income Statement

Balance Sheet

The company has 7.84 million in cash and 8.14 million in debt, giving a net cash position of -295,448 or -0.01 per share.

Cash & Cash Equivalents	7.84M
Total Debt	8.14M
Net Cash	-295,448
Net Cash Per Share	-0.01
Equity (Book Value)	8.00M
Book Value Per Share	0.27
Working Capital	10.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.05 million and capital expenditures -335,148, giving a free cash flow of -10.38 million.

Operating Cash Flow	-10.05M
Capital Expenditures	-335,148
Free Cash Flow	-10.38M
FCF Per Share	-0.35

Full Cash Flow Statement

Margins

Gross margin is -31.80%, with operating and profit margins of -143.50% and -158.37%.

Gross Margin	-31.80%
Operating Margin	-143.50%
Pretax Margin	-158.37%
Profit Margin	-158.37%
EBITDA Margin	-136.41%
EBIT Margin	-143.50%
FCF Margin	n/a

Dividends & Yields

BactiQuant does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.17%
Shareholder Yield	-17.17%
Earnings Yield	-12.41%
FCF Yield	-9.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BactiQuant has an Altman Z-Score of 5.57 and a Piotroski F-Score of 5.

Altman Z-Score	5.57
Piotroski F-Score	5